In 2022 NAnA was awarded a grant from the European Joint Program on Rare Diseases for a project on rare diseases that proposed the organization of a networking event among experts in the field of oncohematology entitled “Highlights in therapy-related myeloid neoplasms.”

The event was held in February 2023 in Rome in the Francesco Mandelli Lecture Hall kindly made available by AIL Nazionale. More than 100 qualified researchers-from 11 different countries-gathered to discuss the development of t-MNs (therapy-related Myeloid Neoplasms) in terms of prevention and treatment, studying the type and dosage of cancer therapy, the aging process, hereditary and environmental risk factors, and genetic abnormalities in hematopoietic stem cells.

Research and innovation in t-MN is also the focus of the discussion, with a dual focus on transposition from research to the patient bedside and industry, as well as health-related quality of life (HRQOL) for cancer survivors.